Efficacy of intraoperative hyperthermic peritoneal perfusion on 60 patients with advanced gastric carcinoma

Chinese Journal of Clinical Oncology

Volumn 37, Issue 4, 2010, Pages 229-231

  Zhan, Hongjie ^a   Liang, Han ^a   Wang, Baogui ^a   Deng, Jingyu ^a   Hao, Xishan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

CA19 9; Carcinoembryonic antigen (CEA); Chemotherapy; Gastric cancer; Regional perfusion; Treatment outcome

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADVANCED CANCER; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTRECTOMY; HUMAN; HYPERTHERMIC THERAPY; INTRAOPERATIVE HYPERTHERMIC PERITONEAL PERFUSION; LYMPH NODE DISSECTION; MULTIPLE CYCLE TREATMENT; PERIPHERAL CIRCULATION; PEROPERATIVE CARE; PROTEIN BLOOD LEVEL; RECURRENCE RISK; STOMACH CARCINOMA; SURVIVAL RATE; THERAPY EFFECT; TUMOR RECURRENCE;

EID: 77949501691     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2010.04.015     Document Type: Article

References (10)

1. Tsujinaka T, Fujitani K, Hirao M, et al. Current status of chemoradiotherapy for gastric cancer in Japan[J]. Int J Clin Oncol, 2008,13(2):117-120.
2. Wu B, Wu D, Wang M, et al. Recurrence in patients following curative resection of early gastric carcinoma[J]. J Surg Oncol. 2008,98(6):411-414.
3. Deraco M, Nonaka D, Baratti D, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion[J]. Ann Surg Oncol, 2006,13(2):229-237.
4. Chinese source
5. Chinese source
6. Chinese source
7. Liang H, Zhan HJ, Wang BG, et al. Change in expression of apoptosis genes after hyperthermia, chemotherapy and radiotherapy in human colon cancer transplanted into nude mice[J]. World J Gastroenterol, 2007,13(32):4365-4371.
8. Levy M, Visokai V, Lipska L, et al. Tumor markers in staging and prognosis of colorectal carcinoma[J]. Neoplasma, 2008,55(2):138-142.
9. Verwaal VJ, Zoetmulder FA. Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin[J]. Eur J Surg Oncol, 2004,30(3):280-285.
10. Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer[J]. EurJ Surg Oncol, 2005,31(2):164-169.